-
Equillium's IPO: What You Need To Know
Friday, October 12, 2018 - 7:24am | 401Equillium is set to begin trading on the Nasdaq Global Market under the ticker symbol “EQ.” The Details Equillium will offer 4.6 million shares of common stock in a price range between $14 and $16 per share. The company intends to raise $70 million, according to the S-1 filing. At the...
-
IPO Outlook For The Week: Biotechs, Batteries And Business Solutions
Sunday, October 7, 2018 - 3:41pm | 304For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. Allogene Therapeutics, Inc. (ALLO) will issue 16 million shares between $16 and $18 Thursday on the Nasdaq. With a portfolio acquired from Pfizer Inc. (NYSE: PFE), the biotech firm develops allogeneic CAR-T therapies...